Tens of thousands of people living with vitiligo affecting their face are to be offered the first approved medicine on the NHS to restore lost skin colour. The new cream, known as ruxolitinib, will be offered to nearly 100,000 people aged 12 and over who have a form of the condition where white patches typically […] This content is
This is mainly useful for treatment counselling, symptom recognition, and outpatient pathway discussions.
ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.